Gastro‑oesophageal reflux disease

Česká verzia

Authors: M. Stefanová
Authors place of work: Nemocnice Na Františku, Praha
Published in the journal: Kardiol Rev Int Med 2014, 16(3): 210-213
Category: Internal Medicine

Summary

Gastro‑oesophageal reflux disease is caused by the return of stomach contents back into the oesophagus. This condition is called gastro‑oesophageal reflux. The most frequent consequence of gastro‑oesophageal reflux is an inflammation of the oesophagus (reflux oesophagitis). The inflammation may be visible during endoscopy as variously extensive erosions or may be established only by microscopy from biopsy (microscopic oesophagitis). Gastro‑oesophageal disease can even be manifested in organs outside the oesophagus as extraoesophageal reflux disease, which often affects mainly the pulmonary system.

Keywords:
reflux – pyrosis – regurgitation – oesophagitis – PPI

Zdroje

1. Bureš J, Koudelka T. Refluxní choroba jícnu. Doporučený diagnostický a léčebný postup pro praktické lékaře. In: Gastroenterologie. Aktualizované doporučené postupy pro praktické lékaře. Praha: Petronius 2003: 11– 16.

2. Lukáš K et al. Refluxní choroba jícnu. Standardy ČGS. Čes Slov Gastroent Hepatol 2003; 57: 23– 29.

3. Kroupa R. Refluxní nemoc jícnu. Med Pro Praxi 2008; 5: 10– 14

4. Hep A, Dolina J. Význam terapeutického testu v diagnostice refluxní choroby jícnu. Interní Med 2003; 5: 240– 242.

5. Edebo A, Vieth M, Tam W et al. Circumferential and axial distribution of esophageal mucosal damage in reflux disease. Dis Esophagus 2007; 20: 232– 238.

6. Richter JE. Gastroesophageal reflux disease. In: Yamada T (ed). Textbook of Gastroenterol. Oxford: Willey‑ Blackwell 2009: 772– 801.

7. Fornari F, Sifrim D. Diagnostic options for patients with refractory GERD. Curr Gastroenterol Rep 2008; 10: 283– 288.

8. Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastro‑ esophageal reflux disease: a global evidence‑based consensus. Am J Gastroenterol 2006; 101: 1900– 1920.

9. Hynie S. Farmakologie v kostce. 2. vyd. Praha: Triton 2001.

10. Špičák J. Inhibitory protonové pumpy: vedlejší účinky a interakce. Gastroent Hepatol 2013; 67: 289– 297.

11. Martínek J, Pantoflícková D, Hucl T et al. Absence of nocturnal acid breakthrough in Helicobacter pylori‑ positive subjects treated with twice‑ daily omeprazole. Eur J Gastroenterol Hepatol 2004; 16: 445– 450.

12. Lukáš K, Bureš J, Drahoňovský V et al. Refluxní choroba jícnu. Standardy České gastroenterologické společnosti – aktualizace 2009. Vnitř Lék 2009; 55: 967– 975.

13. Martínek J, Zavoral M. Barrettův jícen – jak sledovat a jak léčit. Postgraduální medicína 2009; 11: 674– 682.